Pupil size affects coma value in certain eyes

Article

When compared with eyes of normal axial length, high-myopic pseudophakic eyes with posterior staphyloma had significantly less internal coma and less coma variations during mydriasis, according to recently published research.

When compared with eyes of normal axial length, high-myopic pseudophakic eyes with posterior staphyloma had significantly less internal coma and less coma variations during mydriasis, according to research published in Eye.

The researchers studied 60 eyes: 40 in highly myopic cataract patients with posterior staphyloma and 20 in cataract patients with normal axial length.

They found that the high-myopic pseudophakic eyes with posterior staphyloma had significantly lower values of internal coma - both under 4 mm and 6 mm pupil sizes - at 1 month after phacoemulsification and IOL implantation compared to eyes with normal axial length.

The high-myopic pseudophakic eyes with posterior staphyloma also had significantly lower internal total higher-order aberrations and third-order aberrations at 6-mm pupil size.

In addition, the researchers found statistically significant differences between the two groups in the variation from 4- to 6-mm pupil sizes for:

  • internal coma
  • internal third-order aberrations

  • internal total higher-order aberrations
  • ocular coma aberrations.

Strehl ratio increased significantly in high-myopic eyes and decreased slightly in normal axial length eyes after mydriasis, and modular transfer functions were found to vary in a statistically significant manner between the two groups at frequencies of 15, 30, 45 and 60 cycles/degree.

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.